Literature DB >> 22805424

Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design.

V Shakhnovich1, R M Ward, G L Kearns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22805424      PMCID： PMC7704114          DOI： 10.1038/clpt.2012.86

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  25 in total

Review 1.  Do children with gastroesophageal reflux become adults with gastroesophageal reflux? What is the role of Acid suppression in children?

Authors:  John T Boyle; John Co; Geoffrey Davidson; James Freston; Suzanne Nelson; Vasundhara Tolia; Steven L Werlin
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003 Nov-Dec       Impact factor: 2.839

2.  Proton pump inhibitors are associated with lower magnesium levels in older people with chronic kidney disease.

Authors:  Deepa Sumukadas; Marion E T McMurdo; Dirk Habicht
Journal:  J Am Geriatr Soc       Date:  2012-02       Impact factor: 5.562

3.  Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

Authors:  Janet T Holbrook; Robert A Wise; Benjamin D Gold; Kathryn Blake; Ellen D Brown; Mario Castro; Allen J Dozor; John J Lima; John G Mastronarde; Marianna M Sockrider; W Gerald Teague
Journal:  JAMA       Date:  2012-01-25       Impact factor: 56.272

4.  The chemically elegant proton pump inhibitors.

Authors:  Victoria F Roche
Journal:  Am J Pharm Educ       Date:  2006-10-15       Impact factor: 2.047

Review 5.  Proton pump inhibitor use in infants: FDA reviewer experience.

Authors:  Ii-Lun Chen; Wen-Yi Gao; Aisha P Johnson; Ali Niak; John Troiani; Joyce Korvick; Nancy Snow; Kristina Estes; Amy Taylor; Donna Griebel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-01       Impact factor: 2.839

6.  Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease.

Authors:  Jaroslaw Kierkus; Wanda Furmaga-Jablonska; Janice E Sullivan; Elmer S David; Dan L Stewart; Natalie Rath; Caifeng Fu; Wenjin Wang; Mary K Maguire; Gail M Comer
Journal:  Dig Dis Sci       Date:  2010-07-07       Impact factor: 3.199

7.  Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease.

Authors:  Taher Omari; Per Lundborg; Marie Sandström; Patrik Bondarov; Mia Fjellman; Ross Haslam; Geoffrey Davidson
Journal:  J Pediatr       Date:  2009-04-25       Impact factor: 4.406

8.  Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy.

Authors:  S P Nelson; S Kothari; E Q Wu; N Beaulieu; J M McHale; O H Dabbous
Journal:  J Med Econ       Date:  2009       Impact factor: 2.448

Review 9.  Discerning differences: gastroesophageal reflux and gastroesophageal reflux disease in infants.

Authors:  Shawna M Henry
Journal:  Adv Neonatal Care       Date:  2004-08       Impact factor: 1.968

10.  Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study.

Authors:  Hamed Khalili; Edward S Huang; Brian C Jacobson; Carlos A Camargo; Diane Feskanich; Andrew T Chan
Journal:  BMJ       Date:  2012-01-30
View more
  3 in total

Review 1.  Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?

Authors:  Mark Safe; Wei H Chan; Steven T Leach; Lee Sutton; Kei Lui; Usha Krishnan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-11-06

2.  Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach.

Authors:  Florentia Kaguelidou; Corinne Alberti; Valerie Biran; Olivier Bourdon; Caroline Farnoux; Sarah Zohar; Evelyne Jacqz-Aigrain
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

3.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.

Authors:  John J Lima; Cameron D Thomas; Julia Barbarino; Zeruesenay Desta; Sara L Van Driest; Nihal El Rouby; Julie A Johnson; Larisa H Cavallari; Valentina Shakhnovich; David L Thacker; Stuart A Scott; Matthias Schwab; Chakradhara Rao S Uppugunduri; Christine M Formea; James P Franciosi; Katrin Sangkuhl; Andrea Gaedigk; Teri E Klein; Roseann S Gammal; Takahisa Furuta
Journal:  Clin Pharmacol Ther       Date:  2020-09-20       Impact factor: 6.903
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.